Valuation: Futura Medical plc

Market Cap 2.33M 3.13M 2.74M 2.53M 4.4M 302M 4.48M 30.2M 11.84M 148M 11.75M 11.51M 509M P/E 2024
77.2x
P/E 2025 -0.4x
Enterprise Value -1.08M -1.45M -1.27M -1.17M -2.04M -140M -2.07M -13.98M -5.48M -68.32M -5.44M -5.33M -235M EV / Sales 2024
6,428,637x
EV / Sales 2025 1,815,433x
Free-Float
83.88%
Yield 2024 *
-
Yield 2025 -
1 day+11.11%
Current month-23.08%
1 month-27.27%
3 months-65.43%
6 months-70.37%
Current year-64.13%
1 week 0.3
Extreme 0.301
0.5
1 month 0.24
Extreme 0.244
0.7
Current year 0.24
Extreme 0.244
1.75
1 year 0.24
Extreme 0.244
14.85
3 years 0.24
Extreme 0.244
61.5
5 years 0.24
Extreme 0.244
67
10 years 0.24
Extreme 0.244
95.6
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-07
Director of Finance/CFO 46 2018-02-19
Chief Tech/Sci/R&D Officer 74 2016-11-15
Director TitleAgeSince
Director/Board Member 74 2016-03-31
Director/Board Member 46 2018-02-19
Chairman 69 -
Date Insider Type Main position Quantity % Market Cap.
12/8/25 Buy

Chief Technology Officer

500,000 0.1488%
12/8/25 Buy

Chief Financial Officer

500,000 0.1488%
12/8/25 Buy

Chief Executive Officer

5,000,000 1.4876%
Change 5-day change 1-year change 3-year change Capi.($)
+11.11%0.00%-96.10%-99.22% 2.82M
-3.42%+10.05%+58.59%+87.70% 57.82B
-0.05%-6.20%+55.97%+124.61% 53.71B
-2.14%-7.78%+4.46%+421.65% 23.8B
-0.47%-2.11%-17.25%-15.41% 23.26B
-0.56%+10.26%+44.03%-3.86% 20.7B
-0.29%-0.08%+38.91%-27.98% 17.81B
-4.55%-8.65%+194.32%+349.58% 16.9B
-2.61%+8.99%+46.11%+691.67% 16.36B
+0.23%-0.77%+26.37%+187.16% 13.96B
Average -0.27%-0.05%+35.54%+171.59% 24.43B
Weighted average by Cap. -1.62%+0.18%+49.56%+166.57%

Financials

2024 2025
Net sales 13.93 18.77 16.39 15.17 26.34 1.81K 26.82 180.88 70.89 883.99 70.4 68.91 3.05K 1.7 2.29 2 1.85 3.21 220.26 3.27 22.04 8.64 107.7 8.58 8.4 371.13
Net income 1.29M 1.74M 1.52M 1.41M 2.45M 168M 2.49M 16.79M 6.58M 82.08M 6.54M 6.4M 283M -9.07M -12.22M -10.68M -9.88M -17.16M -1.18B -17.47M -118M -46.18M -576M -45.85M -44.89M -1.98B
Net Debt -6.6M -8.89M -7.76M -7.19M -12.48M -856M -12.7M -85.67M -33.58M -419M -33.34M -32.64M -1.44B -3.4M -4.58M -4M -3.71M -6.43M -442M -6.55M -44.18M -17.32M -216M -17.2M -16.83M -744M
Logo Futura Medical plc
Futura Medical plc is a consumer healthcare company that specializes in the development and global commercialization of sexual health products. The Company is a developer of sexual health products, including the lead product, Eroxon, and two products in development, including WSD4000 and Eroxon Intense. Eroxon is a clear gel used for the treatment of erectile dysfunction (ED) available over the counter and without prescription and addresses significant unmet needs in the ED market. Eroxon Intense provides a potential range extension of the Eroxon product and acts as an additional treatment option for men who have ED. WSD4000 is a topical treatment designed for sexual dysfunction in women. The Company has distribution partners in place in a number of major consumer markets, including Haleon in the United States, and Cooper Consumer Health in Europe.
Employees
13
Date Price Change Volume
26-07-16 GBX 0.4000 +11.11% 8,094,994
26-07-15 GBX 0.3600 0.00% 3,587,949
26-07-14 GBX 0.3600 -2.70% 1,549,909
26-07-13 GBX 0.3700 0.00% 10,537,994
26-07-10 GBX 0.3700 -7.50% 12,351,521

Annual profits - Rate of surprise